DiagnaMed Holdings Corp (OTCMKTS:DGNMF) Stock In Focus After Launching PalGPT.ai
Generative AI healthcare solutions company, DiagnaMed Holdings Corp (OTCMKTS:DGNMF), announced the launch of PalGPT.ai, a generative AI brain health solution. This is powered by OpenAI’sChatGPT for people looking for an AI companion for meaningful conversations and sharing inner thoughts.
Trading Data
On Thursday, DGNMF stock ended flat at $0.0361 with more than 30K shares, compared to volume of 4.65K shares. The stock moved within a range of $0.0361 – 0.0361 after opening trade at $0.0692.
DiagnaMed Launches PalGPT.ai, a Generative AI Brain Health Solution
This is the second commercial product from the HealthGenAI division, focusing on the commercialization and development of generative AI ready-made applications. This supports the healthcare market in efficiency, operational workflow, and improving patient outcomes. PalGPT.ai can offer practical advice, emotional support, self-improvement, and resources.
Fabio Chianelli, Chairman of DiagnaMed said that the company is excited to launch second generative AI-powered product, which can ameliorate brain health. The Chairman added that the firm is developing OpenAIChatGPT-powered solutions for those wanting a complementary tool for achieving brain health goals.
The application was born from the firm’s knowledge, and development experience as well as features of the generative AI brain health platform, CERVAI. PalGPT.ai will be incorporated into the platform, providing patients complete suite of solutions to improve brain health.
As per Market.us, generative AI will reach approximately USD 17 billion by 2032 in the healthcare space. This will be driven by the adoption of automation by healthcare operators especially in medical imaging, drug discovery, medical interventions, and hospitals. DiagnaMed is focusing on two divisions- CERVAI™, a generative AI brain health platform, and Health GenAI.
